TELA Bio (TELA)
(Delayed Data from NSDQ)
$1.85 USD
-0.01 (-0.54%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $1.87 +0.02 (1.08%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TELA 1.85 -0.01(-0.54%)
Will TELA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TELA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TELA
NeoGenomics (NEO) Meets Q2 Earnings Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
TELA: What are Zacks experts saying now?
Zacks Private Portfolio Services
TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue Estimates
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates
Other News for TELA
TELA Bio to Announce Second Quarter 2025 Financial Results | TELA Stock News
TELA Bio (TELA) Receives a Buy from Lake Street
12 Health Care Stocks Moving In Monday's After-Market Session
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News
NORTH RUN CAPITAL, LP Acquires Significant Stake in TELA Bio Inc